Physician profile
Shawna R Liszewski
NPI 1578025094
$3,228.10
in general payments reported to CMS, 2019-2025
13 companies · $633 in 2025
The $633 reported for 2025 was more than what 84% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.63 · 2023: $867 · 2024: $1,708 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,771 · Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,770.61 |
| Food and Beverage | $1,437.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,606.89 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Si-Bone, INC. | $886.72 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $168.65 | 2024-2025 | Lifevest |
| Abiomed | $167.37 | 2024-2025 | Impella |
| Medtronic, INC. | $150.75 | 2025 | Hawkone, Penditure |
| Chiesi USA, INC. | $48.26 | 2024-2025 | Kengreal, Cleviprex |
| Surmodics, INC. | $45.52 | 2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Ethicon US, LLC | $44.46 | 2025 | Prolene, Evarrest, Vistaseal |
| Acera Surgical, INC. | $31.69 | 2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $24.57 | 2025 | |
| Terumo Medical Corporation | $24.20 | 2024 | Navicross |
| Lexicon Pharmaceuticals, INC. | $15.32 | 2024 | |
| Bard Peripheral Vascular, INC. | $13.70 | 2025 | Rotarexs 6 F X 135 Cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawna Liszewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.